Lousis Matrix

Sysplatt CV Caps

Product Details

Sysplatt CV Capsule is a powerful cardiovascular protection combination containing Aspirin 75mg, Atorvastatin 10mg, and Clopidogrel 75mg. This medicine helps reduce cholesterol, prevent blood clots, and protect against heart attacks and strokes. It supports long-term heart health in patients with high cardiovascular risk factors like hypertension, diabetes, or previous cardiac events.

Key Features

  • Triple-action formula: Antiplatelet, anti-inflammatory, and lipid-lowering
  • Combines Aspirin, Atorvastatin, and Clopidogrel
  • Reduces risk of heart attack, stroke, and vascular complications
  • Improves blood circulation and prevents artery blockages
  • Controls cholesterol, triglycerides, and LDL levels
  • Ideal for high-risk cardiac patients post-surgery or with existing heart disease

Enquiry Now


We’re Open to Serve You

Sysplatt CV Capsule is a comprehensive cardiovascular care medication, combining Aspirin (75mg), Atorvastatin (10mg), and Clopidogrel (75mg). This combination targets three key risk factors: cholesterol management, blood clot prevention, and inflammation reduction. Aspirin reduces the production of substances responsible for pain, fever, inflammation, and blood clot formation, while Clopidogrel inhibits platelet aggregation, further reducing clotting risk. Atorvastatin lowers harmful cholesterol (LDL) and triglycerides by inhibiting the enzyme responsible for cholesterol production in the liver. 

Together, these actions provide robust protection against heart attacks, strokes, and other cardiovascular events.

Sysplatt CV is commonly prescribed for patients with multiple cardiovascular risk factors, including high cholesterol, atherosclerosis, or a history of heart surgeries like stent placement. It is a trusted therapy for maintaining heart health, preventing artery blockages, and ensuring smooth blood flow. Regular use under medical supervision is essential for achieving long-term cardiovascular protection and optimal lipid profile management.

  • Prevention of heart attack
  • Prevention of stroke
  • Management of high cholesterol levels
  • Reduction of triglyceride levels
  • Control of LDL (bad cholesterol)
  • Prevention of peripheral arterial disease complications
  • Management of acute coronary syndrome
  • Prevention of recurrent cardiovascular events
  • Post-angioplasty or stent care
  • Long-term heart protection in high-risk patients

Sysplatt CV Capsule works through the combined actions of Aspirin, Clopidogrel, and Atorvastatin.

Aspirin inhibits the cyclooxygenase (COX) enzymes, reducing the production of prostaglandins and thromboxane A2, substances that cause inflammation, pain, and promote platelet aggregation. This action helps prevent blood clots from forming.Clopidogrel blocks the P2Y12 ADP receptors on platelets, stopping them from clumping together. This reduces the risk of clot formation inside arteries, which could otherwise lead to heart attacks or strokes.

Atorvastatin inhibits the enzyme HMG-CoA reductase, which is essential for cholesterol synthesis in the liver. By reducing cholesterol production, it lowers LDL (bad cholesterol), triglycerides, and raises HDL (good cholesterol), thus helping to prevent the buildup of fatty plaques in arteries. Together, this combination ensures comprehensive cardiovascular protection by addressing cholesterol levels, reducing inflammation, and preventing dangerous clot formation, keeping blood vessels healthy and reducing the risk of future cardiovascular complications.

Scroll to Top